Researchers from The University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute have used ripretinib and surgical removal of a tumour to successfully treat a patient with recurring gastrointestinal cancer, carrying a KIT exon 11 mutation. The patient received 43 months of treatment, longer than current ripretinib clinical trials, which are reported to have improved clinical outcomes.
Anne Arundel government has made progress in securing systems since cyber incident, officials say – CBS News
Anne Arundel County government officials have reported making progress in securing systems following a cyber incident. Specific details of the incident were not provided, but
